06996

德琪醫藥-B

5.850

-0.090-1.52%
Closed16:08 04/20 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE5.810/5.850
TODAY RANGE5.730-5.920
VOL1.74M
MARKET CAP4.01B
52 WEEK RANGE2.600-8.160
AVG VOL (3M)3.71M
% TURNOVER0.26%
TURNOVER10.14M
P/E (TTM)-15.136
% RANGE3.25%
EPS(TTM)-0.390
P/E(FORWARD)12.532
P/B5.635
BVPS1.047
DIVIDEND--
P/S34.362
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.01B
SHARES OUTSTANDING679.45M
NEXT EARNINGS--
FREE FLOAT679.24M
LOT SIZE500
EX-DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

德琪醫藥-B

06996

-1.52%
5.850

藥明康德

02359

-5.90%
122.900

昊海生物科技

06826

-0.64%
21.740

泰格醫藥

03347

-1.60%
43.080

J

JOINN Laboratories (China)

06127

+3.73%
22.800

康龍化成

03759

+0.09%
21.240

方達控股

01521

+0.96%
1.050

01035

--

08572

--

C

China Health Group

08225

+1.49%
0.136

銘源醫療

00233

0.00%
0.230

維亞生物

01873

-0.52%
1.910

邁博藥業-B

02181

+3.41%
0.455

中國再生醫學

08158

0.00%
0.310

東曜藥業-B

01875

-2.86%
4.750

華領醫藥-B

02552

-2.09%
3.750

微創腦科學

02172

-2.40%
10.960

康寧傑瑞製藥-B

09966

-0.75%
11.900

S

SinoMab BioScience

03681

+1.28%
1.580

樂普生物-B

02157

-2.15%
6.370

J

Jacobio Pharmaceuticals Group

01167

-1.71%
8.060

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.